Buspirone Hydrochloride Tablet
Product Images NDC 71610-826

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (6cc86ab4 6ad4 4adb B9d3 89854ee5b1c5 01)

FDA Label Image

Image-15mg (6cc86ab4 6ad4 4adb B9d3 89854ee5b1c5 02)

This text provides instructions for patients prescribed a 15 mg tablet, detailing the amount of the tablet to take for different dosages: 5 mg (whole tablet), 10 mg (two-thirds of a tablet), 7.5 mg (half of a tablet), and 5 mg (one-third of a tablet).*

FDA Label Image

Image 15mg (6cc86ab4 6ad4 4adb B9d3 89854ee5b1c5 03)

FDA Label Image

Image-30mg (6cc86ab4 6ad4 4adb B9d3 89854ee5b1c5 04)

This text provides dosage guidance for a 30 mg tablet as per your doctor's prescription. It specifies how much of the tablet to take for different amounts, such as the entire tablet, two-thirds, one-half, and one-third.*

FDA Label Image

Image 30mg (6cc86ab4 6ad4 4adb B9d3 89854ee5b1c5 05)

FDA Label Image

Label (71610 826 30)

FDA Label Image

Aphena (Aphena)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.